GB Patent

GB1311956A — Method of potentiating the activity of phosphonomycin antibiotics

Assigned to Merck and Co Inc · Expires 1973-03-28 · 53y expired

What this patent protects

1311956 Potentiated phosphonomycins MERCK & CO Inc 28 Sept 1970 [2 Oct 1969 11 Sept 1970] 46063/70 Heading A5B The antibacterial activity of phosphonomycin antibiotics in non-human animals is potentiated by bringing bacteria into contact with an inducer selected from phosphat…

USPTO Abstract

1311956 Potentiated phosphonomycins MERCK & CO Inc 28 Sept 1970 [2 Oct 1969 11 Sept 1970] 46063/70 Heading A5B The antibacterial activity of phosphonomycin antibiotics in non-human animals is potentiated by bringing bacteria into contact with an inducer selected from phosphatides, sugar phosphates and salts thereof, and polyhydric alcohols, whereby an existing phosphonomycin transport pathway in the bacteria is enhanced or a new such pathway is created, and subsequently or simultaneously bringing the bacteria into contact with a phosphonomycin antibiotic. The invention includes compositions comprising a phosphonomycin antibiotic and an inducer as indicated above.

Drugs covered by this patent

Patent Metadata

Patent number
GB1311956A
Jurisdiction
GB
Classification
—
Expires
1973-03-28
Drug substance claim
No
Drug product claim
No
Assignee
Merck and Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.